Therapy Areas: Cardiovascular
2 April 2026 - Pharmaceutical company Eli Lilly and Company (NYSE:LLY) announced on Wednesday that the US Food and Drug Administration (FDA) has approved Foundayo (orforglipron) for adults with obesit...
31 March 2026 - Pharmaceutical company Hengrui Pharma and Braveheart Bio, a late clinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related conditio...
30 March 2026 - US biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Saturday that Repatha (evolocumab), when added to statins or other low-density lipoprotein cholesterol (LDL-C)-lowering tr...
23 March 2026 - Healthcare solutions provider GE HealthCare (Nasdaq: GEHC) announced on Monday that it has received 510(k) clearance from the U.S. Food and Drug Administration for Photonova Spectra, i...
19 March 2026 - UK biotechnology company IsomAb Ltd announced on Wednesday the appointment of Dr Philip Brainin as chief executive officer and member of the board of directors.IsomAb is developing iso...